Juridisk Institut

The Risk Assessment of Pharmaceuticals in the Environment: EU and US Regulatory Approach

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Dokumenter

DOI

The potential exposure to organisms and humans of pharmaceutical waste presents society with a wicked problem. The health benefits of pharmaceuticals are obvious, but the public awakening to the risks posed by pharmaceutical residues in the environment is in its early stages. Regulators in the US and the EU require an environmental risk assessment of a medicinal product before it can enter the market. This article compares the US and EU approach to assessing these risks, with the purpose of providing a different perspective on how to approach this delicate balancing act of risk and benefit and to reveal the different values underpinning the risk assessment.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Risk Regulation
Vol/bind9
Nummer3
Sider (fra-til)527-547
Antal sider21
ISSN1867-299X
DOI
StatusUdgivet - 1 jun. 2018

Se relationer på Aarhus Universitet Citationsformater

Download-statistik

Ingen data tilgængelig

ID: 122840152